A comparison of prostate cancer survival in England, Norway and Sweden: a population-based study

Cancer Epidemiol. 2012 Feb;36(1):e7-12. doi: 10.1016/j.canep.2011.08.001. Epub 2011 Sep 9.

Abstract

Purpose: The objective of the study was to compare patterns of survival 2001-2004 in prostate cancer patients from England, Norway and Sweden in relation to age and period of follow-up.

Subjects and methods: Excess mortality in men with prostate cancer was estimated using nation-wide cancer register data using a period approach for relative survival. 179,112 men in England, 23,192 in Norway and 59,697 in Sweden were included.

Results: In all age groups, England had the lowest survival, particularly so among men aged 80+. Overall age-standardised five-year survival was 76.4%, 80.3% and 83.0% for England, Norway and Sweden, respectively. The majority of the excess deaths in England were confined to the first year of follow-up.

Conclusion: The results indicate that a small but important group of older patients present at a late stage and succumb early to their cancers, possibly in combination with severe comorbidity, and this situation is more common in England than in Norway or Sweden.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • England / epidemiology
  • Humans
  • Male
  • Mass Screening
  • Norway / epidemiology
  • Prostatic Neoplasms / epidemiology
  • Prostatic Neoplasms / mortality*
  • Public Health Practice
  • Survival Rate
  • Sweden / epidemiology